Gene therapy with angiogenic factors: a new potential approach to the treatment of ischemic diseases

J Mol Cell Cardiol. 1997 Sep;29(9):2311-25. doi: 10.1006/jmcc.1997.0459.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Endothelial Growth Factors / pharmacology
  • Endothelial Growth Factors / physiology
  • Fibroblast Growth Factor 2 / pharmacology
  • Fibroblast Growth Factor 2 / physiology
  • Fibroblast Growth Factor 5
  • Fibroblast Growth Factors / genetics
  • Fibroblast Growth Factors / pharmacology
  • Fibroblast Growth Factors / physiology*
  • Forecasting
  • Gene Transfer Techniques*
  • Genetic Therapy / methods*
  • Genetic Vectors / genetics*
  • Heparin / pharmacology
  • Heparin / physiology
  • Humans
  • Ischemia / therapy*
  • Lymphokines / pharmacology
  • Lymphokines / physiology
  • Neovascularization, Pathologic / physiopathology
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Endothelial Growth Factors
  • FGF5 protein, human
  • Lymphokines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Fibroblast Growth Factor 2
  • Fibroblast Growth Factor 5
  • Fibroblast Growth Factors
  • Heparin